[Indications for tonsillectomy].

Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ (1991) 2.48

Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ (1993) 1.65

Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys (2001) 1.63

[Tumor growth during the waiting period for radiotherapy in patients with oropharyngeal carcinoma]. Ned Tijdschr Geneeskd (2003) 1.42

[Arguments favouring the pharmacotherapy of Bells' palsy]. Ned Tijdschr Geneeskd (2005) 1.40

Long-term quality of life of patients with head and neck cancer. Laryngoscope (2000) 1.32

Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer (2001) 1.30

Warthin's tumour and smoking. B-ENT (2005) 1.17

Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck (2000) 1.13

Psychological factors and patient delay in patients with head and neck cancer. Eur J Cancer (2004) 1.10

A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncol (1999) 1.08

Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. Ann Surg (2000) 1.07

Differences in coping style and locus of control between older and younger patients with head and neck cancer. Clin Otolaryngol (2005) 1.02

F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer. Head Neck (2001) 1.00

A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck (1999) 1.00

Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol (2004) 0.99

The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma. J Craniomaxillofac Surg (1991) 0.98

Negative and positive influences of social support on depression in patients with head and neck cancer: a prospective study. Psychooncology (2000) 0.98

Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma? Clin Otolaryngol Allied Sci (2000) 0.98

Landmarks for parotid gland surgery. J Laryngol Otol (2001) 0.98

T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results. Clin Otolaryngol Allied Sci (1992) 0.97

Synchronous and metachronous tumours in patients with head and neck cancer. J Laryngol Otol (1983) 0.96

Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population. Oral Dis (2007) 0.91

Prognostic factors for survival in patients with T3 laryngeal carcinoma. Am J Surg (1992) 0.91

The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Eur J Cancer B Oral Oncol (1994) 0.90

Prediction of depression 6 months to 3 years after treatment of head and neck cancer. Head Neck (2001) 0.89

Current indications for (adeno)tonsillectomy in children: a survey in The Netherlands. Int J Pediatr Otorhinolaryngol (2003) 0.89

Prediction of depressive symptomatology after treatment of head and neck cancer: the influence of pre-treatment physical and depressive symptoms, coping, and social support. Head Neck (2000) 0.88

Autopsy findings in patients with head and neck squamous cell cancer and their therapeutic relevance. Eur J Cancer B Oral Oncol (1996) 0.86

Ki-67 and p53 in T2 laryngeal cancer. Laryngoscope (1998) 0.86

A review of clinical trials regarding treatment of acute otitis media. Clin Otolaryngol Allied Sci (1992) 0.86

Tympanic membrane grafting with fascia, pericardium and vein. J Laryngol Otol (1982) 0.86

Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol (1998) 0.86

Synovial sarcoma of the pharynx. Ear Nose Throat J (1984) 0.86

Medical care-seeking and health-risk behavior in patients with head and neck cancer: the role of health value, control beliefs and psychological distress. Health Educ Res (2005) 0.85

18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer (1999) 0.85

Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab Invest (1999) 0.84

Treatment of localized non-Hodgkin's lymphomas of the head and neck. Cancer (1994) 0.84

Leishmania braziliensis presenting as a granulomatous lesion of the nasal septum mucosa. J Laryngol Otol (1997) 0.83

The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med (1999) 0.82

Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis. Int J Radiat Oncol Biol Phys (1991) 0.81

Radiotherapy in epithelial tumors of the parotid gland: case presentation and literature review. Int J Radiat Oncol Biol Phys (1990) 0.81

Elderly patients with head and neck cancer: short-term effects of surgical treatment on quality of life. Clin Otolaryngol Allied Sci (2003) 0.81

Preoperative determination of the location of parotid gland tumors by analysis of the position of the facial nerve. J Oral Maxillofac Surg (2001) 0.81

A gene expression profile for non-smoking and non-drinking patients with head and neck cancer. Oral Dis (2011) 0.80

Uni- and multivariate analysis of eight indications for post-operative radiotherapy and their significance for local-regional cure in advanced head and neck cancer. J Laryngol Otol (1993) 0.80

The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography. Oral Oncol (1999) 0.79

The value of twice yearly bronchoscopy in the work-up and follow-up of patients with laryngeal cancer. Eur J Cancer (1993) 0.79

FDG positron emission tomography in head and neck cancer: pitfall or pathology? Clin Nucl Med (1999) 0.79

Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital. Clin Otolaryngol Allied Sci (2004) 0.79

Mechanisms of acquired resistance to methotrexate in a human squamous carcinoma cell line of the head and neck, exposed to different treatment schedules. Eur J Cancer (1991) 0.78

Persistence of middle ear dysfunction after recurrent acute otitis media. Clin Otolaryngol Allied Sci (1994) 0.78

[Annual chest X-ray in patients after treatment for laryngeal or oral cancer: only a limited number of second primary lung cancers detected]. Ned Tijdschr Geneeskd (1999) 0.78

Efficacy of sinus irrigation versus sinus irrigation followed by functional endoscopic sinus surgery. Ann Otol Rhinol Laryngol (1997) 0.78

Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging. J Nucl Med (1998) 0.78

Optimal regimes for local IL-2 tumour therapy. Int J Cancer (1996) 0.78

Proliferative capacity in head and neck cancer. Head Neck (2001) 0.77

Carcinomas of the maxillary sinus: a retrospective study. Clin Otolaryngol Allied Sci (1985) 0.77

Microbiology of chronic maxillary sinusitis in adults: isolated aerobic and anaerobic bacteria and their susceptibility to twenty antibiotics. Acta Otolaryngol (1995) 0.77

Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients. Eur J Cancer B Oral Oncol (1996) 0.77

Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresis. Cancer (1996) 0.77

Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study regarding Tobacco and Alcohol Consumption. Patholog Res Int (2011) 0.77

Degree of tumour differentiation as a prognostic factor in advanced laryngeal cancer. Acta Otorhinolaryngol Belg (1995) 0.76

Guidelines in head and neck oncology compliance and consequences of deviations from the standard protocol for tongue and floor of mouth squamous carcinoma. Clin Otolaryngol (2005) 0.76

Local control in T3 laryngeal cancer treated with radical radiotherapy, time dose relationship: the concept of nominal standard dose and linear quadratic model. Int J Radiat Oncol Biol Phys (1991) 0.76

In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate. Int J Cancer (1992) 0.76

Prognostic significance of cell proliferation markers and DNA-ploidy in head and neck tumors. Int J Radiat Oncol Biol Phys (1998) 0.76

Professional delay in head and neck cancer patients: analysis of the diagnostic pathway. Oral Oncol (2006) 0.76

p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases. Oral Oncol (1999) 0.76

Cause of death in squamous cell carcinoma of the head and neck. An autopsy study on 31 patients. J Craniomaxillofac Surg (1992) 0.76

Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium. J Oral Pathol Med (2008) 0.76

Sluder's neuralgia: a trigeminal autonomic cephalalgia? Cephalalgia (2010) 0.75

Chemodectoma (paraganglioma) of the larynx. Clin Otolaryngol Allied Sci (1981) 0.75

Is antibiotic treatment of chronic sinusitis effective in children? Clin Otolaryngol Allied Sci (1994) 0.75

Improved depiction of pterygopalatine fossa anatomy using ultrahigh-resolution magnetic resonance imaging at 7 tesla. ScientificWorldJournal (2012) 0.75

Pathologic Quiz Case 2. Diffuse oncocytosis of the parotid glands. Arch Otolaryngol (1981) 0.75

Squamous carcinoma of the adolescent larynx. Ear Nose Throat J (1981) 0.75

Protein tyrosine kinase activity in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol (1993) 0.75

Carcinoma of the nasal vestibule: prognostic factors in relation to lymph node metastasis. Clin Otolaryngol Allied Sci (1985) 0.75

Value of sinus radiographs in the diagnosis of maxillary sinus disease: interobserver agreement on sinus radiographs by otolaryngologists and radiologists. Clin Otolaryngol Allied Sci (1996) 0.75

Treatment of advanced laryngeal cancer (T3-4). Acta Otorhinolaryngol Belg (1992) 0.75

Measurement of folylpolyglutamate synthetase activity in head and neck squamous carcinoma cell lines and clinical samples using a new rapid separation procedure. Oncol Res (1992) 0.75

[Obstructive sleep apnea in childhood]. Ned Tijdschr Geneeskd (1990) 0.75

The high-risk group in early glottic carcinoma. Arch Otolaryngol (1980) 0.75

[Cervical lymph node metastasis of an unknown primary tumor]. Ned Tijdschr Geneeskd (1987) 0.75

Thyroglossal cysts and fistulae. Ear Nose Throat J (1984) 0.75

Squamous carcinoma of the nasal vestibule. Clin Otolaryngol Allied Sci (1981) 0.75

Non-Hodgkin's lymphoma of Waldeyer's ring. Cancer (1985) 0.75

[Primary tumors of the lung in patients with squamous cell carcinoma of the head and neck region: a challenge]. Ned Tijdschr Geneeskd (1987) 0.75

The importance of vocal cord mobility in T2 laryngeal cancer. Radiother Oncol (1990) 0.75

Benign lymphoepithelial lesion and malignancy. Arch Otorhinolaryngol (1981) 0.75

[Earache, itch and exudate as symptoms of a sick ear]. Ned Tijdschr Geneeskd (1987) 0.75

Nasal discharge and obstruction as presenting symptoms of Wegener's granulomatosis in childhood. Int J Pediatr Otorhinolaryngol (1993) 0.75

Regression after 50 Gy as a selection for therapy in advanced laryngeal cancer. Int J Radiat Oncol Biol Phys (1988) 0.75

[Treatment of cystic fibrosis]. Ned Tijdschr Geneeskd (1986) 0.75

[Physical examination of patients with an unknown primary tumor]. Ned Tijdschr Geneeskd (1986) 0.75

[Is there a role for radiotherapy in the treatment of patients with pleomorphic adenoma of the parotid gland?]. Ned Tijdschr Geneeskd (1989) 0.75

Membrane transport of methotrexate in a squamous carcinoma cell line adapted to low folate concentrations. Anticancer Res (1991) 0.75

[Transmeatal inner ear damage]. Ned Tijdschr Geneeskd (1982) 0.75

Primary hypothyroidism as a complication after treatment of tumours of the head and neck. Acta Radiol Oncol (1982) 0.75